Celerion, a global leader of early clinical development services to the pharmaceutical industry, offers a unique combination of:
medical expertise – clinical operations – scientific excellence
First-in-Human to Proof-of-Concept as well as larger Phase II studies:
- clinical study conduct, data management and biometrics, PK/PD analysis, bioanalytical services (onsite laboratories), medical writing,regulatory and drug development program management.
- safety/tolerability, bioequivalence and bioavailability, drug-drug interaction, cardiovascular safety, ADME, renal & hepatic, respiratory, vaccines, infectious disease and oncology
- Exploring drug effects in both healthy volunteer and patient studies